Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
23.16
-0.43 (-1.82%)
At close: Nov 20, 2026, 4:00 PM EST
23.16
0.00 (0.00%)
After-hours: Nov 20, 2026, 7:30 PM EST
Rapport Therapeutics Employees
Rapport Therapeutics had 84 employees as of December 31, 2025. The number of employees increased by 15 or 21.74% compared to the previous year. That makes Rapport Therapeutics the 32,550th largest employer in the world and 4,205th in the United States.
Employees
84
Change (1Y)
15
Growth (1Y)
21.74%
Revenue / Employee
$238,095
Profits / Employee
-$1,791,310
Market Cap
1.37B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 84 | 15 | 21.74% |
| Dec 31, 2024 | 69 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Immunocore Holdings | 524 |
| Intellia Therapeutics | 377 |
| Ocular Therapeutix | 325 |
| Nuvation Bio | 310 |
| UroGen Pharma | 300 |
| AnaptysBio | 104 |
| Taysha Gene Therapies | 99 |
RAPP News
- 4 days ago - Rapport Therapeutics Transcript: Jefferies Global Healthcare Conference - Transcripts
- 9 days ago - Rapport Therapeutics Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 15 days ago - Rapport Therapeutics price target lowered to $64 from $71 at UBS - TheFly
- 15 days ago - Rapport Therapeutics price target lowered to $66 from $70 at Guggenheim - TheFly
- 15 days ago - Rapport Therapeutics price target lowered to $47 from $50 at Wells Fargo - TheFly
- 16 days ago - Rapport Therapeutics reports Q3 EPS (84c), consensus ($1.22) - TheFly
- 16 days ago - Rapport Therapeutics Reports Third Quarter 2026 Financials and Provides Business Update - GlobeNewsWire
- 16 days ago - Rapport Therapeutics Earnings release: Q3 2026 - Filings